Level of S-100 and neuro specific enolase in cerebrospinal fluid from subjects with neurological pathologies;Niveles de S-100 y enolasa neuroespecífica en líquido cefalorraquídeo de enfermos con patología neurológica

Revista Espanola de Medicina Nuclear

Volumn 22, Issue 4, 2003, Pages 238-243

  Infante, J R ^a   Martinez A ^a   Ochoa, J ^a   Canadillas F ^a   Torres Avisbal, M ^a   Vallejo, J A ^a   Gonzalez F M ^a   Pacheco, C ^a   Latre, J M ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Cerebrospinal fluid; Neuro specific enolase; Neurological disorders; S 100

Indexed keywords

ENOLASE; PSORIASIN; BIOLOGICAL MARKER; NERVE PROTEIN; PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CHILD; CONTROLLED STUDY; DEMENTIA; HUMAN; MALE; MENINGITIS; MOTOR NEURON DISEASE; NEUROLOGIC DISEASE; POLYNEUROPATHY; PUNCTURE; BRAIN DISEASE; CEREBROVASCULAR DISEASE; CHRONIC BRAIN DISEASE; FEMALE; INFANT; MIDDLE AGED; PRESCHOOL CHILD; PROTEIN CEREBROSPINAL FLUID LEVEL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BRAIN DAMAGE, CHRONIC; BRAIN DISEASES; CEREBROSPINAL FLUID PROTEINS; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; DEMENTIA; FEMALE; HUMANS; INFANT; MALE; MENINGITIS; MIDDLE AGED; NERVE TISSUE PROTEINS; PHOSPHOPYRUVATE HYDRATASE; RETROSPECTIVE STUDIES; S100 PROTEINS;

EID: 0141923546     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/s0212-6982(03)72192-2     Document Type: Article

References (22)

1. Isobe T, Takahashi K, Okuyama T. S-100ao protein is present in neurons of central and peripheral nervous system. J Neurochem 1984;43:1494-6.
2. Marangos P, Schmedel D, Parma A, Clark R, Goodwin F. Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue. J Neurochem 1979;33:319-29.
3. Tapia F, Polak J, Barbosa A, Bloom S, Marangos P, Dermody C, et al. Neuron-specific enolase is produced by neuroendocrine tumours. Lancet 1981;1:808-11.
4. Bonfrer JM, Korse CM. Monitoring malignant melanoma with the S100B tumor marker. Recent Results Cancer Res 2001;158:149-57.
5. Büttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 1997;28:1961-5.
6. Mokuno K, Koyosawa K, Sugimura K, Yasuda T, Riku S, Murayama T, et al. Prognostic value of cerebrospinal fluid neuron-specific enolase and S-100b protein in Guillain-Barré syndrome. Acta Neurol Scan 1994;89:27-30.
7. Infante JR, Torres-Avisbal M, Martínez A, Vallejo JA, Aguilera C, Contreras P, et al. Evaluation of tumor maker S-100 in cerebrospinal fluid from sujects with nonischemic brain pathologies. Tumor Biol 2000;21:38-45.
8. Brown K, Kynoch P, Thompson R. Immunoreactive nervous system specific enolase (14-3-2 protein) in human serum and cerebrospinal fluid. Clin Chem Acta 1980;101:257-64.
9. Sindic CJ, Chalon MP, Cambiaso CL, Laterre EC, Masson PL. Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1982;45:1130-5.
10. Lamers KJ, Van Engelen BG, Gabreels FJ, Hommes OR, Borm GF, Wevers RA. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders. Acta Neurol Scan 1995;92:247-51.
11. Ashwal S, Tomasi L, Schneider S, Perkin R, Thompson J. Bacterial meningitis in children: Pathophysiology and treatment. Neurology 1992;42:739-48.
12. Mokuno K, Kato K, Kawi K, Matsuoka Y, Yanagi T, Sobue I. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci 1983;60:443-51.
13. Green AJ, Harvey RJ, Thompson EJ, Rossor MN. Increased S-100beta in cerebrospinal fluid of patients with frontotemporal dementia. Neurosci Lett 1997;253:5-8.
14. Pemberton LA, Brew BJ. Cerebrospinal fluid S100beta and its relationship with AIDS dementia complex. J Clin Virol 2001;22:249-53.
15. Otto M, Stein H, Szudra A, Zerr I, Bodemer M, Gefeller O, et al. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 1997;244:566-70.
16. Zerr I, Bodemer M, Racker S, Grosche S, Poser S, Kretzschmar H, et al. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995;345:1609-10.
17. Nagamatsu M, Mokuno K, Sugimura K, Kiyosawa K, Aoki S, Takahashi A, et al. Cerebrospinal fluid levels of S-100b protein and neuron-specific enolase in chronic inflammatory demyelinating polyneuropathy. Acta Neurol Scan 1995;91:483-7.
18. Dyck P, Lais A, Ohta M, Bastron J, Okazaki H, Groover R. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50:621-37.
19. Persson L, Hardemark HG, Gustafsson J, Rundstrom G, Mendel-Hartvig I, Esscher T, et al. S-100 protein and neuro-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987;18: 911-8.
20. Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuchi E. S100ao protein in blood and urine during open heart surgery. Clin Chem 1989;35:1942-4.
21. Nygaard O, Langbakk B, Romner B. Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder. Clin Chem 1997;43:541-3.
22. Nygaard O, Langbakk B, Romner B. Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder. Scan J Clin Lab Invest 1998;58:183-6.